Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matías A Avila

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Hepatology|November 19, 2010
Long distance calling for liver regeneration: identification of neuroendocrine signalling pathways activated after partial hepatectomyMatías A Avila
Journal of Hepatology|July 7, 2022
Hydroxymethylbilane synthase (aka porphobilinogen deaminase): A novel metabolic tumor suppressor gene in hepatocellular carcinomaAntonio Fontanellas, Matías A Avila
Gastroenterology|March 7, 2018
Inhibiting Cytokinesis in the Liver: A New Way to Reduce Tumor DevelopmentChantal Desdouets, Matías A Avila
Cellular and Molecular Life Sciences : CMLS|June 20, 2015
Regulation of hepatocyte identity and quiescenceCarmen Berasain, Matías A Avila
Cellular and Molecular Gastroenterology and Hepatology|December 12, 2018
Targeting CCL2/CCR2 in Tumor-Infiltrating Macrophages: A Tool Emerging Out of the Box Against Hepatocellular CarcinomaMatías A Avila, Carmen Berasain
Journal of Gastroenterology|December 10, 2013
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesisCarmen Berasain, Matías A Avila
Hepatology (Baltimore, Md.)|January 11, 2014
Deciphering liver zonation: new insights into the β-catenin, Tcf4, and HNF4α triadCarmen Berasain, Matías A Avila
Seminars in Cell & Developmental Biology|January 28, 2014
AmphiregulinCarmen Berasain, Matías A Avila
Cellular and Molecular Gastroenterology and Hepatology|December 1, 2021
HIF2α Activation in NASH: A New Force Pushing Toward HCCAlex Clavería-Cabello, Matías A Avila
Journal of Physiology and Biochemistry|October 20, 2023
Frontiers in fatty liver: recent advances in pathogenic mechanisms, assessment of patients' prognosis and pharmacotherapy : MASLD: new pathogenic mechanisms, risk assessment tools and drug therapiesMaite G Fernández-Barrena, Matías A Avila
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|November 19, 2010
Long distance calling for liver regeneration: identification of neuroendocrine signalling pathways activated after partial hepatectomyMatías A Avila
Journal of Hepatology|July 7, 2022
Hydroxymethylbilane synthase (aka porphobilinogen deaminase): A novel metabolic tumor suppressor gene in hepatocellular carcinomaAntonio Fontanellas, Matías A Avila
Gastroenterology|March 7, 2018
Inhibiting Cytokinesis in the Liver: A New Way to Reduce Tumor DevelopmentChantal Desdouets, Matías A Avila
Cellular and Molecular Life Sciences : CMLS|June 20, 2015
Regulation of hepatocyte identity and quiescenceCarmen Berasain, Matías A Avila
Cellular and Molecular Gastroenterology and Hepatology|December 12, 2018
Targeting CCL2/CCR2 in Tumor-Infiltrating Macrophages: A Tool Emerging Out of the Box Against Hepatocellular CarcinomaMatías A Avila, Carmen Berasain
Journal of Gastroenterology|December 10, 2013
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesisCarmen Berasain, Matías A Avila
Hepatology (Baltimore, Md.)|January 11, 2014
Deciphering liver zonation: new insights into the β-catenin, Tcf4, and HNF4α triadCarmen Berasain, Matías A Avila
Seminars in Cell & Developmental Biology|January 28, 2014
AmphiregulinCarmen Berasain, Matías A Avila
Cellular and Molecular Gastroenterology and Hepatology|December 1, 2021
HIF2α Activation in NASH: A New Force Pushing Toward HCCAlex Clavería-Cabello, Matías A Avila
Journal of Physiology and Biochemistry|October 20, 2023
Frontiers in fatty liver: recent advances in pathogenic mechanisms, assessment of patients' prognosis and pharmacotherapy : MASLD: new pathogenic mechanisms, risk assessment tools and drug therapiesMaite G Fernández-Barrena, Matías A Avila
Pageof 8